Last Updated: 17 Sep 2024
Executive Summary
Inspire Medical Systems Inc. (INSP) is a medical technology company that focuses on developing and commercializing minimally invasive solutions for patients with obstructive sleep apnea (OSA). The company's latest stock price is $207.93. Analysts have a strong buy rating on the stock, with a target price of $226.38. The company has a strong revenue growth and profitability. However, it is still operating at a loss.
Company Overview
Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota. The company's primary product is the Inspire Upper Airway Stimulation (UAS) therapy system, which is a minimally invasive treatment for OSA. The Inspire system is implanted under the skin and stimulates the hypoglossal nerve, which controls the muscles that open the airway.
Fundamental Analysis
Inspire Medical Systems has been growing rapidly in recent years. Revenue increased by 29.6% in the most recent quarter, and the company is expected to continue to grow at a strong pace in the coming years. The company is still operating at a loss, but it is expected to become profitable in the next few years.
The company's financial ratios are mixed. The trailing PE ratio is high at 1019.95, but the forward PE ratio is more reasonable at 153.85. The price-to-sales ratio is also high at 8.62. However, the company's gross margin and operating margin are both improving.
Technical Analysis
The technical analysis of Inspire Medical Systems is mixed. The stock price is currently trading below its 50-day moving average and its 200-day moving average. The relative strength index (RSI) is also below 50, which indicates that the stock is oversold. However, the moving average convergence divergence (MACD) indicator is showing a bullish crossover, which suggests that the stock price may be ready to move higher.
Short Term Outlook
The short-term outlook for Inspire Medical Systems is mixed. The stock price is currently trading below its moving averages and the RSI is oversold. However, the MACD indicator is showing a bullish crossover. The stock price could move higher in the short term, but it is also possible that it could continue to trade sideways or even move lower.
Long Term Outlook
The long-term outlook for Inspire Medical Systems is positive. The company is growing rapidly and is expected to continue to grow at a strong pace in the coming years. The company is still operating at a loss, but it is expected to become profitable in the next few years. The stock price could continue to move higher in the long term as the company continues to grow and becomes profitable.
Analyst Recommendations
Analysts have a strong buy rating on Inspire Medical Systems. The average target price is $226.38, which represents a potential upside of 9.1% from the current price. Two analysts have a strong buy rating, ten have a buy rating, seven have a hold rating, and none have a sell or strong sell rating.
